A Study to Learn About the Safety of TALZENNA for the Treatment of Breast Cancer
Clinical trial NCT06735742 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06735742
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-04-12
- Primary completion
- 2029-03-30
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.